Delivery Order SPE2DB22D2206-SPE2DB24FKC38

Award Date 9/3/24
Potential Completion Date 9/4/24
Potential Value $41K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ORENCIA 125 MG/ML SYRINGEML. The $5,280.09 firm fixed-price contract has a period of performance through February 7, 2025. It is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a wide range of pharmaceutical products and medical supplies,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ORENCIA 125 MG/ML syringes. The $2,960.46 firm-fixed-price contract has an ultimate completion date of April 24, 2023. This award is under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables the efficient...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ORENCIA 125 MG/ML SYRINGEML, a pharmaceutical product, with a ceiling value of $40,477.39. The contract is a Firm Fixed Price arrangement and has an ultimate completion date of May 27, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of ORENCIA 125 MG/ML SYRINGEML, a medication, with a ceiling value of $34,483.75 and a performance period through May 21, 2025. The contract is a firm fixed-price, non-set-aside award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ORENCIA 125 MG/ML SYRINGEML, a pharmaceutical product, with a ceiling value of $10,470.71. The contract is a firm fixed-price delivery order without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,313.48 firm-fixed-price contract is for the supply of Orencia 125 mg/mL syringes, with a completion date of November 22, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of ORENCIA 125 MG/ML SYRINGEML. The contract has a ceiling value of $9,862.26 and a period of performance through August 6, 2024. It is a firm fixed-price contract. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract as part of its extensive work supplying medications and medical supplies to various federal agencies and healthcare...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ORENCIA 125 MG/ML SYRINGE/ML, with a firm fixed price ceiling value of $7,926.57 and a period of performance through May 20, 2025. The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a $14,282.52 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ORENCIA 125 MG/ML SYRINGE, a pharmaceutical product, with a period of performance through May 13, 2025. There is no set-aside designation for this contract, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. The $24,044.52 firm-fixed-price contract is for the supply of ORENCIA CLICKJECT 125 MG/MLML, a prescription medication. The contract has an ultimate completion date of October 16, 2024 and is not designated as a set-aside award. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FKC38
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of ORENCIA 125 MG/ML SYRINGES. The $40,976.29 fixed-price contract has a period of performance through September 4, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 12/3/24, 10:07 AM